In the setting of IBD-associated renal dysfunction, the concentrations of IAA achieved through oral supplementation likely fall within a “therapeutic window,” activating protective pathways such as Nrf2 and AhR and exerting anti-inflammatory and antioxidant effects [24,59,60]. This evidence concerns the gene AHR and inflammatory bowel disease.